HC Wainwright Issues Pessimistic Estimate for ABEO Earnings

Abeona Therapeutics Inc. (NASDAQ:ABEO – Free Report) – Investment analysts at HC Wainwright lowered their Q1 2026 earnings per share (EPS) estimates for shares of Abeona Therapeutics in a research report issued on Monday, August 18th. HC Wainwright analyst R. Selvaraju now anticipates that the biopharmaceutical company will earn $0.04 per share for the quarter, […]

Leave a Reply

Your email address will not be published.

Previous post TSE:CHE FY2026 EPS Boosted by National Bank Financial
Next post Zacks Research Issues Negative Forecast for HII Earnings